Results 291 to 300 of about 2,200,142 (368)

First‐in‐Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy Participants

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Oral small molecule inhibitors of tumor necrosis factor alpha (TNFα) are emerging as attractive therapeutic agents for the treatment of various autoimmune diseases. Balinatunfib (SAR441566), a novel oral inhibitor of tumor necrosis factor receptor 1 (TNFR1) signaling, changes the configuration of the soluble TNFα (sTNFα) trimer and prevents its ...
Nassr Nassr   +12 more
wiley   +1 more source

Cytomegalovirus host receptor expression in the human fetal inner ear. [PDF]

open access: yesPLoS One
Grijpink LCM   +5 more
europepmc   +1 more source

Methodology of high‐dimensional flow cytometry in monitoring immune microenvironment of pituitary neuroendocrine tumors

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Characterization of the tumor immune microenvironment (TIME) of pituitary neuroendocrine tumors (PitNETs) is crucial for understanding the behavior of different types of PitNETs and identification of possible causes of their aggressiveness, rapid growth, and resistance to therapy.
Marina Yu Loguinova   +13 more
wiley   +1 more source

<i>Vibrio</i> MARTX toxin binding of biantennary N-glycans at host cell surfaces. [PDF]

open access: yesSci Adv
Chen J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy